HP Inc. Declares Dividend

PALO ALTO, Calif., June 10, 2025 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2894 per share on the company’s common stock.

Source: https://www.globenewswire.com/news-release/2025/06/10/3097152/0/en/HP-Inc-Declares-Dividend.html

Tags
cash
cash dividend
common stock
company
dividend
news
NYSE:HPQ
PER
share
source
stock
US40434L1052

Personal Loan Authority Announces Official Website Update Featuring Financial Wellness Support for Emergency Cash Access

BrightSpring Announces Secondary Offering of Common Stock

globenewswire

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

Commodities & Resources PTE Ltd. Announces Acquisition of Shares of Belmont Resources Inc. Pursuant to Private Placement

Gwo Xi Stem Cell Company Powers Local Regenerative Medicine, Partners with Japan to Open a New Era

APPLOVIN ALERT: Bragar Eagel & Squire, P.C. is Investigating AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

HP Inc. Declares Dividend

Commodities & Resources PTE Ltd. Announces Acquisition of Shares of Belmont Resources Inc. Pursuant to Private Placement

Gwo Xi Stem Cell Company Powers Local Regenerative Medicine, Partners with Japan to Open a New Era

World’s Best Glacier Photos Launch in Global “Walk of Water” Exhibition

APPLOVIN ALERT: Bragar Eagel & Squire, P.C. is Investigating AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Eye Level Malaysia Ignites Learning Joy with Mid-Year Promo & Exclusive Block Sets!

Minsud Announces Closing of Over-Subscribed Private Placement

Recent News

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition

Explore

Press Releases

News & Opinion

Living

Others

Follow us

Monetary Metals Welcomes Brent Johnson to its Advisory Board

“SNL: Ladies & Gentlemen…50 Years of Music” Now Open at The Rock & Roll...

INTRICA Wins a 2025 Global Recognition Award for Innovation in Sustainable Manufacturing and Design...